Private Equity

Prism Capital

Investment Details

Investor Type
Private Equity

Asset Class Focus
Private Equity, Venture Capital

Stage Focus
Early Stage, Growth, Late Stage

Geographical Focus
United States

Industries Focus

  • Technology
  • Healthcare
  • Manufacturing
  • Services

Investment Size:
2,000,000 to 15,000,000 USD

Investor Details Founded: 1999

Prism Capital is a Chicago-based private equity firm established in 1999, focusing on providing equity and mezzanine capital to lower middle market companies. The firm managed the Prism Opportunity Fund, a growth equity fund, and the Prism Mezzanine Fund, focusing on lower-middle market subordinated debt investments. ([prismfund.com](https://www.prismfund.com/?utm_source=openai))

The Prism Opportunity Fund invested in 14 companies, including SecurePipe, a digital security firm which merged with Trustwave; Celleration, a medical device company sold to Alliqua BioMedical; HighBeam Research, sold to Gale (part of Cengage Learning); SterilMed, sold to Great Hill Partners and Primus Capital; Banner Service Corp; and Fieldglass, sold to Madison Dearborn Partners. ([prismfund.com](https://www.prismfund.com/?utm_source=openai))

In 2011, the firm's partners began winding down the fund to pursue other interests, and they remain actively involved in winding down the remaining fund’s assets on behalf of their Limited Partners. ([prismfund.com](https://www.prismfund.com/?utm_source=openai))

Requirements
  • Focus on lower middle market companies
  • Interest in growth equity and mezzanine capital investments
  • Preference for investments in the United States
Contact

[Official Website Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • SecurePipe
  • Celleration
  • HighBeam Research
  • SterilMed
  • Banner Service Corp
  • Fieldglass
Claim this Investor

Are you an official representative of Prism Capital?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim